OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
Trial details
- Registry ID
- NCT05814757
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)NCT05814757 | OCUL | Phase 2 | Completed | 2024-05-22Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |